+ 49 (0) 2204 2918806
Manufacturer: GlobalData

Healthcare, Regulatory and Reimbursement Landscape - Sweden

Publication Date:31.03.2013
Language version:English
Report Type:Report
Lieferzeit:2-3 Tage
Nr of pages:197 pages
Rating:Für diese Studie liegt keine Bewertung vor.
$1,995.00   *
* Click here to switch the currency you want to pay in.
More about this report
Table of Contents
Other relevant reports
Our guarantee

Content of the report


GlobalData, the industry analysis specialist, has released its new report “Healthcare, Regulatory and Reimbursement Landscape - Sweden”. The report is an essential source of information and analysis on Sweden’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and healthcare infrastructure. Most importantly, it provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.

Sweden’s population was 9.6 million in 2012 and is increasing due to a positive balance between the birth and death rate, and immigration. Policymakers are additionally presented with the problem of an increasing unemployment rate due to a lack of clear monetary policies. The pharmaceutical market was estimated at $5.7 billion in 2011 and is expected to reach approximately $6.9 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 2.6%. The medical device market was estimated at approximately $2.6 billion in 2012 and is expected to reach $3.8 billion by 2020 at a CAGR of 5.1%. These positive trends can primarily be attributed to -
- Increasing access to healthcare facilities
- Government initiatives to promote competition in the healthcare sector
- Revised reimbursement and pricing policies for pharmaceuticals


The report provides information on Sweden’s healthcare, regulatory and reimbursement landscape, and includes -
- Overview of the pharmaceutical and medical devices markets, comprising size, segmentation and key drivers and barriers
- Profiles and SWOT analysis of the major players in the pharmaceutical and medical devices market, namely AstraZeneca, Merck, Novartis, Orifarm and Pfizer. The major players covered for the medical devices market are Abbott Laboratories, Essilor International, F. Hoffmann-La Roche, Medtronic, and Siemens Healthcare.
- Insightful review of the reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies and approval processes for new drugs
- Detailed analysis of the political and economic environment, including economic indicators, demographics, and healthcare infrastructure and expenditure
- Overview of the opportunities for and challenges to growth in the healthcare market


Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Sweden’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Sweden’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
- Identify, understand and capitalize on the opportunities and challenges in Sweden’s healthcare market